Zoekresultaten
  1. 30 jun.

    -cas9 Knippen en plakken Met dna/rna

  2. 16 uur geleden

    gene editing could reach patients ‘very soon’: Intellia CEO - via

    3 retweets 4 vind-ik-leuks
  3. 1 jul.

    Explore our article collection ‘Editing the Genome’ for reviews addressing current and future applications of CRISPR and CRISPR-Cas adaptive immune systems.

    13 retweets 69 vind-ik-leuks
  4. 1 jul.

    I am looking very much forward to a hopefully open discussion.

    Almost there. Götz Hensel, University of Duesseldorf and I give a lecture on green genetic engineering for the local Green Party in Erftstadt near Cologne, and other interested people. I´m very curious to see how the evening will go.
    1 retweet 26 vind-ik-leuks
  5. 1 jul.

    Announcement 3: Exciting and High Impact Postdoc Opportunity Exploring CRISPR engineering and Directed Evolution (email: maresso@bcm.edu if interested)

    18 retweets 24 vind-ik-leuks
  6. 2 jul.

    The first company files for an IPO:

    CRISPR company Caribou Biosciences filed for an IPO! As a nerd who lives in Berkeley, I am having a real "Our little child is all grown up" feeling about this news.
    1 antwoord 3 retweets 21 vind-ik-leuks
  7. 1 jul.

    We’re taking a full-spectrum approach to leveraging the power of to develop both in vivo and ex vivo therapies for a broad range of diseases. Learn about our modular platform:

    4 retweets 17 vind-ik-leuks
  8. 30 jun.

    Congratulations to Mammoth Co-Founder and CTO, , who has been recognized as one of ’s “Innovators Under 35”! Check out this article to learn more about Janice’s pioneering work in diagnostics and generally:

    49 retweets 158 vind-ik-leuks
  9. 2 jul.

    We are getting serious with . Impressive work by and Eva Quandt.

    1 retweet 27 vind-ik-leuks
  10. 1 jul.

    3rd postdoc position in our lab. ! Ohh cooool!!

    Announcement 3: Exciting and High Impact Postdoc Opportunity Exploring CRISPR engineering and Directed Evolution (email: maresso@bcm.edu if interested)
    9 retweets 15 vind-ik-leuks
  11. 1 jul.

    Fantastic news and a big booster for the field. Congrats to all involved!

    News: Today we open a . We’re proud to announce the first clinical data suggesting a single infusion of may potently and precisely inactivate a disease-causing gene, opening the door to treating, reversing or curing previously inaccessible diseases.
    Deze collectie tonen
    1 retweet
  12. 29 jun.

    This is a big moment for the patients we hope to serve with NTLA-2001 – and for all who can benefit from the promise of genomic medicine. Our CEO, John Leonard, reflects on this milestone:

    2 retweets 20 vind-ik-leuks
  13. 28 jun.

    Hear from one of our founders, Rodolphe Barrangou, on this exciting moment in medicine here:

    2 retweets 12 vind-ik-leuks
  14. 5 jul.

    calling !!!

    Please retweet. Join our team! We are looking for a Postdoc in molecular biology and its potential applications to plant breeding. Funding available for up to 4 years. Apply here:
    3 vind-ik-leuks
  15. 4 jul.

    This is how the EndoSeek project appeared - ENDOmetriosis and its “Hide and Seek” from us. In order to find it, we decided to develop a detection system based on the technique

    1 antwoord 2 vind-ik-leuks
    Deze collectie tonen
    Deze collectie tonen
  16. 29 jun.

    Need help with scientific details of your gene editing experiment? Sign up for our virtual course to interact with the experts & receive feedback on your project. 📅 Apply by 12 July, 2021 🌐

    5 retweets 14 vind-ik-leuks
  17. 3 jul.

    What are the Cas proteins behind ? Check out very first blog post to find out:

    1 retweet 1 vind-ik-leuk
  18. 28 jun.

    has 'gene edited' some stock prices today 🧬 Intellia CRISPR Therapeutics Editas

    12 antwoorden 20 retweets 273 vind-ik-leuks
  19. 2 jul.

    A breakthrough in the treatment of an inherited disease using is meaningful to the Leber congenital amaurosis community as well. Editas Medicine is in trials with CRISPR gene-editing to restore vision in patients with ().

    2 retweets 2 vind-ik-leuks
  20. 2 jul.

    midday update 📈$BEAM 134.29 (+.52%) 📈$VERV 53.35 (+.40%) 📉$CRSP 155.66 (-.52%) 📉$EDIT 55.32 (-2.12%) 📉$NTLA 166.42 (-3.05%) 📉$GRPH 27.29 (-3.40%)

    1 antwoord 4 vind-ik-leuks

Geen resultaten.

Het laden lijkt wat langer te duren.

Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.